The non-genomic crosstalk between PPAR-γ ligands and ERK1/2 in cancer cell lines

Author： Papageorgiou Efstathia   Pitulis Nea   Msaouel Pavlos   Lembessis Peter   Koutsilieris Michael  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.8, 2007-08, pp. : 1071-1085

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Basis for the Design of PPAR-#947; Ligands: A Survey on Quantitative Structure- Activity Relationships

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 9, 2009-08 ,pp. : 1075-1083

Bentham Science Publishers

Access to resources Recommend Favorite

The Non-Genomic Effects of the PPAR#946;#947; Agonist GW0742 on Streptozotocin Treated Rat Aorta

By  

Current Molecular Pharmacology, Vol. 11, Iss. 2, 2018-04 ,pp. : 149-154

Bentham Science Publishers

Access to resources Recommend Favorite

Relationship Between Non-Genomic Actions of Estrogens and Insulin Resistace

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 48-51

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 460-471

Bentham Science Publishers

Access to resources Recommend Favorite

Pro12Ala and His447His polymorphisms of PPAR-γ are associated with polycystic ovary syndrome

By Gu Bon-Hee   Baek Kwang-Hyun  

Reproductive BioMedicine Online, Vol. 18, Iss. 5, 2009-05 ,pp. : 644-650

Reproductive Healthcare Ltd

Access to resources Recommend Favorite